CHU Reims

Running trials

• Recruiting

  Fight Osteosarcoma Through European Research Evolving Study Platform From Diagnosis to Relapse

  NCT07871864· Phase 3· Source

• Not yet recruiting

  Multicenter Prospective Study Analyzing the Occurrence of Multiple Sclerosis Relapses Without Radiological Evidence: Myth or Reality?

  NCT07545889· Source

• Recruiting

  Effect of Exercise Order During Pulmonary Rehabilitation on Muscle Strength in Patients With COPD

  NCT07655011· Source

• Not yet recruiting

  Functional Magnetic Resonance Imaging Study of Inhibitory Control in Bipolar Disorder and Major Depressive Disorder

  NCT07503275· Source

• Not yet recruiting

  Survival Without Persistent Limiting Toxicity: Real Life Prospective Cohort of Advanced Neuroendocrine Tumor

  NCT07471425· Source

• Recruiting

  Determinants and Consequences of the Transition to Adulthood for Adolescents With Severe Haemophilia: TRANSHEMO 2, an Ancillary Study to the TRANSHEMO Project

  NCT07418827· Source

• Recruiting

  Prospective Dynamic Cohort Study of Phenotypic Profiles in Patients With Chronic Obstructive Pulmonary Disease

  NCT07627763· Source

• Recruiting

  A Cohort for Inflammatory Respiratory Diseases: From Phenotyping to Personalised Medicine

  NCT07274631· Source

• Recruiting

  Long-term Evaluation of the SIMEOX Device at Home in Non-cystic Fibrosis Bronchiectasis

  NCT06487273· Source

• Recruiting

  Social Cognition, Memory, and Executive Functions in Bipolar Disorder and Major Depressive Disorder

  NCT06740331· Source

• Recruiting

  Effect at 3 Months of Early Empagliflozin Initiation in Cardiogenic Shock Patients on Mortality, Rehospitalization, Left Ventricular Ejection Fraction and Renal Function.

  NCT05879276· Phase 3· Source

• Recruiting

  Study of Vitamin B12 Metabolism in Children With Sickle Cell Disease Exposed to MEOPA

  NCT06581900· Source

• Recruiting

  Developmental and Epileptic Encephalopathy of Genetic Etiology: Natural History Through Reuse of Clinical Data

  NCT06380192· Source

• Recruiting

  Evaluation of the Vivo Isar Stent System in Routine Clinical Practice

  NCT06420505· Source

• Recruiting

  Neutrophil Extracellular Traps in Different Forms of Systemic Sclerosis

  NCT06462768· Source

• Recruiting

  SIOPEN BIOPORTAL, An International Registry Linked to a Virtual Biobank for Patients With Peripheral Neuroblastic Tumours

  NCT05192980· Source

• Active, not recruiting

  Study Investigating the Association of NP137 With Atezolizumab-Bevacizumab Combination in First Line in Unresectable HCC

  NCT05546879· Phase 1· Source

• Recruiting

  Description of the Immune Deficiency in Patients With Untreated Chronic Lymphocytic Leukemia and Search for Predictive Factors of Infectious Risk

  NCT06475469· Source

• Active, not recruiting

  STop and Restart Acalabrutinib In fRail Patients With Previously Untreated Chronic Lymphocytic Leukemia

  NCT04963946· Phase 2· Source

• Recruiting

  Securing Access to Innovative Molecules in Oncology and Hematology for Children, Adolescents and Young Adults

  NCT04477681· Source

• Recruiting

  Social Cognition in Pediatric Epilepsy

  NCT04253379· Source

• Active, not recruiting

  Observational Study in Patients Treated With JAK Inhibitors for Inflammatory Rheumatism (MAJIK)

  NCT04602091· Source

• Recruiting

  Soluble Cluster of Differentiation 160 (sCD160) in Sera and Intra-ocular Fluids: Association With Ischaemic Retinopathies

  NCT03680794· Source

• Active, not recruiting

  Development and Progression of Carcinoid Heart Disease in a Cohort of Adult Patients With Neuroendocrine Tumors

  NCT03498040· Source

• Recruiting

  Autoreactive Anti-Ro/SSA IgE To Determine Primary SjögRen's Syndrome's Disease Activity

  NCT03003572· Source

• Enrolling by invitation

  Juvenile Inflammatory Rheumatism (JIR) Cohorte

  NCT02377245· Source

• Recruiting

  UroCCR Database: French Research Network for Kidney Cancer -UroCCR

  NCT03293563· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Childhood cancers3 recruiting
• COPD3 recruiting
• Bipolar disorder2 recruiting
• Cystic fibrosis2 recruiting
• Depression2 recruiting
• Epilepsy2 recruiting
• ANCA-associated vasculitis1 recruiting
• Asthma1 recruiting
• Chronic lymphocytic leukaemia1 recruiting
• Coronary artery disease1 recruiting
• Diabetic eye disease1 recruiting
• Haemophilia1 recruiting
• Heart failure1 recruiting
• Kidney cancer1 recruiting
• Lupus (SLE)1 recruiting
• Multiple sclerosis1 recruiting
• Neuroblastoma1 recruiting
• Neuroendocrine tumours1 recruiting
• Rheumatoid arthritis1 recruiting
• Sarcoma1 recruiting
• Sickle cell disease1 recruiting
• Sjögren's disease1 recruiting
• Systemic sclerosis (scleroderma)1 recruiting

Researchers

No researcher is linked here yet.

Closed trials

• Completed

  Prevalence and Factors Associated With Sleep Disorders in Inflammatory Bowel Disease

  NCT06439641· Source

• Completed

  Objective and Perceived Health Status of Elderly People With Moderate or Severe Haemophilia in France: an Ancillary Study of the FranceCoag Registry

  NCT05218772· Source

• Completed

  Evaluation of a New Screening Method for Sarcopenia in Rheumatoid Arthritis

  NCT04933097· Source

• Completed

  Evaluation of a Modified Anti-Platelet Therapy Associated With Low-dose DES Firehawk in Acute Myocardial Infarction Patients Treated With Complete Revascularization Strategy

  NCT04753749· Source

• Terminated

  Futibatinib Versus Gemcitabine-Cisplatin Chemotherapy as First-Line Treatment of Patients With Advanced Cholangiocarcinoma Harboring FGFR2 Gene Rearrangements

  NCT04093362· Phase 3· Source

• Completed

  Home Airway Clearance in CF Patients

  NCT04096664· Source

• Completed

  Evaluation of Risk-Adapted and MRD-Driven Strategy for Untreated Fit Patients With Intermediate Risk Chronic Lymphocytic Leukemia

  NCT04010968· Phase 2· Source

• Completed

  Rotation or Change of Biotherapy After TNF Blocker Treatment Failure for Axial Spondyloarthritis

  NCT03445845· Phase 4· Source

• Completed

  Neoadjuvant mFolfirinox With or Without Preoperative Concomitant Chemoradiotherapy in Patients With Borderline Resectable Pancreatic Carcinoma (PANDAS-PRODIGE 44)

  NCT02676349· Phase 2· Source

• Completed

  Preoperative Inflammatory Markers Predict Postoperative Complications After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Colorectal Carcinomatosis

  NCT06318793· Source